The Calmer Co International Ltd is raising up to $3.5 million through a 1-for-1 renounceable entitlement offer priced at $0.001 per share, including free attaching options exercisable at $0.002. The capital will fund debt repayment, inventory expansion, marketing, and product launches.
- 1-for-1 renounceable entitlement offer at $0.001 per share
- Free attaching options exercisable at $0.002, expiring in 2.5 years
- Offer partly underwritten by Mahe Capital up to $500,000
- Funds to repay secured convertible notes and support US and Australian expansion
- Eligible shareholders in Australia, New Zealand, Fiji, and the US
Capital Raise Details and Offer Structure
The Calmer Co International Ltd (ASX:CCO) has launched a renounceable entitlement offer aiming to raise up to $3.5 million by issuing 3.5 billion new shares at a deeply discounted price of $0.001 each, representing a 50% discount to the last closing price of $0.002. Eligible shareholders will receive one free attaching option for every two new shares subscribed, exercisable at $0.002 and expiring 2.5 years after issue.
The offer is renounceable, allowing shareholders to trade their rights on the ASX or transfer them privately. A Top Up Offer enables shareholders who fully subscribe to their entitlement to apply for additional shares subject to availability and allocation discretion. Any shortfall shares may be placed within three months post-closing.
Use of Proceeds and Financial Position
Proceeds from the capital raise will primarily be allocated to repaying $1.4 million in secured convertible notes, expanding inventory for both wholesale and retail channels, including the recently approved Fiji Kava® FZZR™ product, and supporting marketing initiatives in Australia and the USA. The company also plans new product launches and to bolster general working capital.
The company’s latest reviewed financials show a modest net asset position of $187,326 as of 31 December 2025, which would improve to approximately $3.7 million post-raise. The repayment of secured debt is expected to reduce long-term liabilities by $1.4 million, easing financial pressure.
Underwriting and Director Participation
The entitlement offer is partially underwritten up to $500,000 by Mahe Capital Pty Ltd, who will receive up to 70 million options as part of their fee. Directors James Tonkin and Griffon Emose have also committed to sub-underwriting portions of the offer, potentially increasing their voting power to around 1.7% and 1.8% respectively if fully called upon.
All directors have indicated their intention to participate in the offer, signalling confidence in the company’s prospects. The underwriting arrangements and allocation policies are designed to avoid any shareholder exceeding 20% voting power, maintaining control balance.
Risks and Dilution Impact
The company cautions that failure to participate will likely result in dilution of approximately 50% of existing shareholdings, rising to about 60% if all attaching options are exercised. The offer is described as speculative, with numerous risks including ongoing going concern uncertainties, customer concentration, debt refinancing needs, and product liability exposure.
Market acceptance of new products and international expansion efforts, particularly in the USA and Australia, remain critical to the company’s growth strategy. The company’s recent success in securing Coles ranging for FZZR and growing US sales underpin this strategy but also highlight the importance of the capital raise to support scaling operations and inventory.
Offer Timetable and Eligibility
The offer opens on 4 August 2026 and closes on 17 August 2026, with rights trading commencing on 29 July and ending on 10 August. Eligible shareholders are those registered with addresses in Australia, New Zealand, Fiji, and the United States (limited to institutional accredited investors). Ineligible shareholders will have their entitlements sold on their behalf with proceeds remitted.
The new shares will rank equally with existing shares, while the options will be quoted subject to ASX discretion. The company estimates approximately $270,000 in cash costs related to the offer.
Shareholders and prospective investors are advised to carefully consider the offer prospectus and consult professional advisers given the speculative nature and risks involved.
Bottom Line?
The Calmer Co’s $3.5 million entitlement offer aims to shore up balance sheet and fuel growth but poses dilution risks that shareholders must weigh carefully.
Questions in the middle?
- Will the entitlement offer fully subscribe or leave a significant shortfall?
- How will the company balance debt repayment with funding expansion if the raise falls short?
- What impact will the dilution from options exercise have on shareholder value over time?